Susquehanna International Group’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$366K Sell
204,488
-194,392
-49% -$412K ﹤0.01% 10424
2025
Q4
$893K Buy
398,880
+143,876
+56% +$378K ﹤0.01% 7438
2025
Q3
$617K Buy
255,004
+133,681
+110% +$356K ﹤0.01% 8483
2025
Q2
$71.8K Sell
121,323
-15,677
-11% -$12.2K ﹤0.01% 11974
2025
Q1
$120K Buy
137,000
+87,206
+175% +$121K ﹤0.01% 11410
2024
Q4
$84.2K Buy
+49,794
New +$89.8K ﹤0.01% 11443
2024
Q2
Sell
-20,748
Closed -$55.7K 12979
2024
Q1
$34K Sell
20,748
-11,448
-36% -$16.8K ﹤0.01% 11675
2023
Q4
$57.3K Buy
+32,196
New +$69K ﹤0.01% 11664
2023
Q3
Sell
-57,123
Closed -$639K 12760
2023
Q2
$639K Buy
+57,123
New +$608K ﹤0.01% 7733

Other funds holding PROK

Susquehanna International Group's PROK Position: Q1 2026 in Review

Susquehanna International Group reduced its ProKidney (PROK) stake by 49% in Q1 2026, selling an estimated $412K and leaving 204,488 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #10424.

Susquehanna International Group first reported a position in PROK in Q2 2023 and has held it in 9 quarters since. The position peaked at $893K in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Susquehanna International Group held 204,488 shares of ProKidney worth $366K as of Q1 2026.
  • Susquehanna International Group sold 194,392 ProKidney shares in Q1 2026, an estimated $412K.
  • ProKidney made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10424 holding.
  • Susquehanna International Group first reported a position in ProKidney in Q2 2023 and has held it in 9 quarters since.
  • Susquehanna International Group's ProKidney position peaked at $893K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.